Related references
Note: Only part of the references are listed.KEGG Mapper for inferring cellular functions from protein sequences
Minoru Kanehisa et al.
PROTEIN SCIENCE (2020)
miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database
Hsi-Yuan Huang et al.
NUCLEIC ACIDS RESEARCH (2020)
Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling
Jia-Li Tao et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)
2019 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
RNAi therapeutic and its innovative biotechnological evolution
Yuhua Weng et al.
BIOTECHNOLOGY ADVANCES (2019)
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Cristian Turato et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Recognition Sites for Cancer-targeting Drug Delivery Systems
Siyu Guan et al.
CURRENT DRUG METABOLISM (2019)
2018 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2019)
Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level
Dong Wang et al.
NUCLEIC ACIDS RESEARCH (2018)
Magnesium-Stabilized Multifunctional DNA Nanoparticles for Tumor-Targeted and pH-Responsive Drug Delivery
Haoran Zhao et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
2017 FDA drug approvals The FDA approved 46 new drugs last year, the highest total in more than two decades
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2018)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
Meike H. van der Ree et al.
LANCET (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
2016 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2017)
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
Wenkang Luan et al.
ONCOTARGETS AND THERAPY (2017)
MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells
Koichiro Minami et al.
ONCOTARGET (2017)
miRNA nanotherapeutics for cancer
Aditya Ganju et al.
DRUG DISCOVERY TODAY (2017)
Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis
Zhou Xu et al.
NEURO-ONCOLOGY (2016)
Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer
Zhiqiang Ye et al.
TUMOR BIOLOGY (2016)
Negative correlation of ITCH E3 ubiquitin ligase and miRNA-106b dictates metastatic progression in pancreatic cancer
Zhu-lin Luo et al.
ONCOTARGET (2016)
3B, a novel photosensitizer, inhibits glycolysis and inflammation via miR-155-5p and breaks the JAK/STAT3/SOCS1 feedback loop in human breast cancer cells
Kecheng Lei et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression
Dong-liang Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
2015 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2016)
E2F1-miR-20a-5p/20b-5p auto-regulatory feedback loop involved in myoblast proliferation and differentiation
Wen Luo et al.
SCIENTIFIC REPORTS (2016)
Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1
Zhiqiang Ye et al.
CANCER BIOLOGY & THERAPY (2015)
miR-122-A key factor and therapeutic target in liver disease
Simonetta Bandiera et al.
JOURNAL OF HEPATOLOGY (2015)
MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma
Xiuming Zhu et al.
PLOS ONE (2015)
MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1
Kang Han et al.
ONCOTARGET (2015)
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Gloria Bertoli et al.
THERANOSTICS (2015)
MicroRNA miR-21 Attenuates Human Cytomegalovirus Replication in Neural Cells by Targeting Cdc25a
Ya-Ru Fu et al.
JOURNAL OF VIROLOGY (2015)
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis
Surajit Pathak et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
miR-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2
Li Ying Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Therapeutic targeting of microRNAs: current status and future challenges
Zhonghan Li et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer
Qifeng Luo et al.
ONCOLOGY REPORTS (2014)
MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2
Tao Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The Alteration of MiR-222 and Its Target Genes in Nickel-Induced Tumor
Jing Zhang et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2013)
Resistance to EGFR blockade in colorectal cancer: liquid biopsies and latent subclones
David J. Konieczkowski et al.
CELL RESEARCH (2013)
Progress in microRNA delivery
Yu Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Natural RNA circles function as efficient microRNA sponges
Thomas B. Hansen et al.
NATURE (2013)
Prognostic Implications of MicoRNA miR-195 Expression in Human Tongue Squamous Cell Carcinoma
Ling-fei Jia et al.
PLOS ONE (2013)
miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1
Chaoyang Sun et al.
ONCOLOGY LETTERS (2013)
MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1
Jing Liu et al.
BMC CANCER (2012)
MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
J. Ryan et al.
BRITISH JOURNAL OF CANCER (2012)
Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF
Jun Zhang et al.
FEBS LETTERS (2012)
Oral delivery of small RNA and DNA
Diane C. Forbes et al.
JOURNAL OF CONTROLLED RELEASE (2012)
MicroRNA-21 Inhibitor Sensitizes Human Glioblastoma U251 Stem Cells to Chemotherapeutic Drug Temozolomide
Shuguang Zhang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion
Qian-Qian Zhang et al.
NEURO-ONCOLOGY (2012)
A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
Marcella Cesana et al.
CELL (2011)
The ClinicalTrials.gov Results Database - Update and Key Issues
Deborah A. Zarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
Chen Xie et al.
NUCLEIC ACIDS RESEARCH (2011)
MicroRNA-193b Represses Cell Proliferation and Regulates Cyclin D1 in Melanoma
Jiamin Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity
XueLi Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells
Carmen Doebele et al.
BLOOD (2010)
Regulation of Minichromosome Maintenance Gene Family by MicroRNA-1296 and Genistein in Prostate Cancer
Shahana Majid et al.
CANCER RESEARCH (2010)
MicroRNA-141 Regulates Smad Interacting Protein 1 (SIP1) and Inhibits Migration and Invasion of Colorectal Cancer Cells
Minghua Hu et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma
Lu Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons
Elisa Vilardo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Xing J. Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinoma
Junfang Ji et al.
JOURNAL OF HEPATOLOGY (2010)
MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1
Wen Pan et al.
JOURNAL OF IMMUNOLOGY (2010)
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
N. M. Alajez et al.
CELL DEATH & DISEASE (2010)
MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor
Jun Tie et al.
PLOS GENETICS (2010)
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation
Deepa Sampath et al.
BLOOD (2009)
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Ramiro Garzon et al.
BLOOD (2009)
microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells
Peng Wang et al.
CANCER RESEARCH (2009)
MicroRNA-661, a c/EBPα Target, Inhibits Metastatic Tumor Antigen 1 and Regulates Its Functions
Sirigiri Divijendra et al.
CANCER RESEARCH (2009)
MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
Laura Gramantieri et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma
Yukiharu Hiyoshi et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNA-101 Regulates Expression of the v-fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) Oncogene in Human Hepatocellular Carcinoma
Shuai Li et al.
HEPATOLOGY (2009)
Identification of MicroRNA-181 by Genome-Wide Screening as a Critical Player in EpCAM-Positive Hepatic Cancer Stem Cells
Junfang Ji et al.
HEPATOLOGY (2009)
MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
Shoumei Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Characterization of an NF-κB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells
Aileen I. Pogue et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
Dawn R. Cochrane et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
Aly A. Khan et al.
NATURE BIOTECHNOLOGY (2009)
被撤回的出版物: Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer SUPPRESSION OF TUMORIGENIC PROPERTY OF LUNG CANCER CELLS AND THEIR SENSITIZATION TO DOXORUBICIN-INDUCED APOPTOSIS BY miR-1 (Retracted article. See vol. 293, pg. 12945, 2018)
Mohd W. Nasser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
miR-122, a paradigm for the role of microRNAs in the liver
Muriel Girard et al.
JOURNAL OF HEPATOLOGY (2008)
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
Catherine Labbaye et al.
NATURE CELL BIOLOGY (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
F. Fornari et al.
ONCOGENE (2008)
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Sooryanarayana Varambally et al.
SCIENCE (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
Chemical modification: the key to clinical application of RNA interference?
David R. Corey
JOURNAL OF CLINICAL INVESTIGATION (2007)
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Dirk Grimm et al.
NATURE (2006)
Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles
RH Muller et al.
JOURNAL OF BIOTECHNOLOGY (2004)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)